Whole-body glucose turnover was measured by determining the specific activity of glucose in the steady-state plasma using a scintillation counter. Hepatic glucose production was assumed to represent ∼90% of the measured whole-body glucose turnover based on our previously published data (7 (link)). Liver-specific metabolic flux rates were calculated using a combined NMR-LC-MS/MS method. We corrected for the natural abundance of each metabolite included in the flux calculations, measuring all possible enrichments (for instance, m+0, m+1, m+2, m+3, and m+4 for malate) and correcting the measured peak areas to account for the fact that once a carbon is labeled it can no longer contribute to the natural abundance (10 (link)). Samples were prepared for NMR by homogenizing 2–3 g of liver in 5 volumes of 7% perchloric acid. The pH of the samples was adjusted to 6.8–7.3 using 30% potassium hydroxide and 7% perchloric acid as necessary, and the samples were centrifuged at 4000 × g for 10 min. The supernatant was frozen in liquid N2 and lyophilized. 13C NMR analysis was performed as described by Befroy et al. (6 (link)). Total glucose and alanine enrichment was measured by GC/MS and glutamate by LC-MS/MS, with 13C NMR used to algebraically divide the total enrichment to determine the enrichment of each carbon of these metabolites.
We calculated the [2-13C]malate enrichment by relating the positional enrichments of malate to those measured in glutamate assuming (and validating) full equilibration across fumarase as shown in Equations 1 and 2.


For calculation of the liver-specific metabolic flux ratio VPyr-Cyc/VMito = (VPK + VME, out)/(VPC + VME, in+ VPDH), we used our previously published isotopic labeling model (6 (link), 7 (link)) extended using a mass isotopomer multiordinate spectral analysis approach to take into account VPK and unlabeled mass entry from propionate at the succinyl-CoA step of the TCA cycle (10 (link)). Here, VME, out refers to ME flux in the direction of pyruvate synthesis; VME, in refers to the reverse reaction of pyruvate into malate, and VLDH refers to pyruvate synthesis via LDH. With these fluxes taken into account, we can describe the steady-state mass balance at pyruvate with Equation 3,
and isotope balance at [2-13C]pyruvate with Equation 4,

Because the positional enrichments of pyruvate and PEP cannot be measured reliably using our NMR-LC-MS/MS techniques, we use the following label substitutions shown in Equations 5 and 6,


Substituting Equations 5 and 6 into Equation 4 and rearranging, we derive Equation 7,

By separating out like terms, we get Equation 8,
where VPDH denotes flux through pyruvate dehydrogenase; VCS denotes flux through citrate synthase; VPK denotes flux through pyruvate kinase; VME, out denotes flux through malic enzyme from malate to pyruvate; VME, in denotes flux through malic enzyme from pyruvate to malate; and VPC denotes flux through pyruvate carboxylase. Additional fluxes shown in the complete flux diagram in Fig. 1 are VGNG OAA gluconeogenesis from oxaloacetate, VGNG total gluconeogenesis, and Vprop the rate of propionate entry into the TCA cycle. VPDH/VCS was measured using the ratio [4-13C]glutamate/[3-13C]alanine, as described by Alves et al. (11 (link)).
Free full text: Click here